Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 241, Issue 7, 2003, Pages 567-570

  Bandello, Francesco ^a   Lanzetta, Paolo ^a   Parodi, Maurizio Battaglia ^b   Roman Pognuz, Derri ^a   Saviano, Sandro ^b   Ravalico, Giuseppe ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; MALE; MYOPIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; CHOROID; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; MYOPIA; NEOVASCULARIZATION, PATHOLOGIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RECURRENCE; RETREATMENT; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 0041560918     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-003-0686-9     Document Type: Article

References (11)

1. Battaglia Parodi M, Da Pozzo S, Ravalico G (2003) Angiographic features after photodynamic therapy for choroidal neovascularization in age-related macular degeneration and pathologic myopia. Br J Ophthalmol 87:177-183
2. Brancato R, Pece A, Avanza P, Raddrizzani E (1990) Photocoagulation scar expansion after laser therapy of choroidal neovascularization in degenerative myopia. Retina 10:239-243
3. Curtin J (1985) The myopias. Basic science and clinical management. Harper & Row, Philadelphia, 7-10
4. Curtin J (1985) The myopias. Basic science and clinical management. Harper & Row, Philadelphia, 309-330
5. Husain D, Kramer M, Kenny AG et al (1999) Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment. Invest Ophthalmol Vis Sci 40:2322-2331
6. Lim JI, VIP Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization (CNV) in pathologic myopia using verteporfin: two-year result. VIP Report #4 [ARVO Abstract] Invest Ophthalmol Vis Sci 42(4):S304, abstract 1637
7. Pece A, Brancato R, Avanza P, Camesasca F, Galli L (1995) Laser photocoagulation of choroidal neovascularization in pathologic myopia: long-term results. Int Ophthalmol 18:339-344
8. Soubrane G, Coscas G, Kuhn D (1999) Myopia. In: Guyer DR, Yannuzzi LA, Chang S, Shields JA, Green WR (eds) Retina, vitreous, macula. Saunders, Philadelphia, pp 189-205
9. Soubrane G, Pison J, Bornert P, et al (1986) Néo-vaisseaux sou-rétiniens de la myopie dégénérative: résultates de la photocoagulation: Bull Soc Ophtalmol Fr 86:269-272
10. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP report no. 1. Arch Ophthalmol 117:1329-1345
11. Verteporfin in Photodynamic Therapy (VIP) Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial. VIP report no. 1. Ophthalmology 108:841-852